These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 36553250)

  • 1. CDKL5 Deficiency Disorder (CDD)-Rare Presentation in Male.
    Rodak M; Jonderko M; Rozwadowska P; Machnikowska-Sokołowska M; Paprocka J
    Children (Basel); 2022 Nov; 9(12):. PubMed ID: 36553250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vagus nerve stimulation for the treatment of refractory epilepsy in the CDKL5 Deficiency Disorder.
    Lim Z; Wong K; Downs J; Bebbington K; Demarest S; Leonard H
    Epilepsy Res; 2018 Oct; 146():36-40. PubMed ID: 30071384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CDKL5 deficiency disorder in males: Five new variants and review of the literature.
    Siri B; Varesio C; Freri E; Darra F; Gana S; Mei D; Porta F; Fontana E; Galati G; Solazzi R; Niceta M; Veggiotti P; Alfei E
    Eur J Paediatr Neurol; 2021 Jul; 33():9-20. PubMed ID: 33989939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical manifestations and epilepsy treatment in Japanese patients with pathogenic CDKL5 variants.
    Kobayashi Y; Tohyama J; Takahashi Y; Goto T; Haginoya K; Inoue T; Kubota M; Fujita H; Honda R; Ito M; Kishimoto K; Nakamura K; Sakai Y; Takanashi JI; Tanaka M; Tanda K; Tominaga K; Yoshioka S; Kato M; Nakashima M; Saitsu H; Matsumoto N
    Brain Dev; 2021 Apr; 43(4):505-514. PubMed ID: 33436160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclin-Dependent Kinase-Like 5 Deficiency Disorder: Clinical Review.
    Olson HE; Demarest ST; Pestana-Knight EM; Swanson LC; Iqbal S; Lal D; Leonard H; Cross JH; Devinsky O; Benke TA
    Pediatr Neurol; 2019 Aug; 97():18-25. PubMed ID: 30928302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CDKL5 Deficiency Disorder-Related Epilepsy: A Review of Current and Emerging Treatment.
    Hong W; Haviland I; Pestana-Knight E; Weisenberg JL; Demarest S; Marsh ED; Olson HE
    CNS Drugs; 2022 Jun; 36(6):591-604. PubMed ID: 35633486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current neurologic treatment and emerging therapies in CDKL5 deficiency disorder.
    Olson HE; Daniels CI; Haviland I; Swanson LC; Greene CA; Denny AMM; Demarest ST; Pestana-Knight E; Zhang X; Moosa AN; Fidell A; Weisenberg JL; Suter B; Fu C; Neul JL; Percy AK; Marsh ED; Benke TA; Poduri A
    J Neurodev Disord; 2021 Sep; 13(1):40. PubMed ID: 34530725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation and characterization of human induced pluripotent stem cells (iPSCs) from three male and three female patients with CDKL5 Deficiency Disorder (CDD).
    Chen PF; Chen T; Forman TE; Swanson AC; O'Kelly B; Dwyer SA; Buttermore ED; Kleiman R; Js Carrington S; Lavery DJ; Swanson LC; Olson HE; Sahin M
    Stem Cell Res; 2021 May; 53():102276. PubMed ID: 33714067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CDKL5 deficiency disorder: clinical features, diagnosis, and management.
    Leonard H; Downs J; Benke TA; Swanson L; Olson H; Demarest S
    Lancet Neurol; 2022 Jun; 21(6):563-576. PubMed ID: 35483386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CDKL5 deficiency causes epileptic seizures independent of cellular mosaicism.
    Takahashi S; Takeguchi R; Tanaka R; Fukuoka M; Koike T; Ohtani H; Inoue K; Fukuda M; Kurahashi H; Nakamura K; Tominaga K; Matsubayashi T; Itoh M; Tanaka T
    J Neurol Sci; 2022 Dec; 443():120498. PubMed ID: 36417806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical manifestation of CDKL5 deficiency disorder and identified mutations in a cohort of Slovak patients.
    Kluckova D; Kolnikova M; Medova V; Bognar C; Foltan T; Svecova L; Gnip A; Kadasi L; Soltysova A; Ficek A
    Epilepsy Res; 2021 Oct; 176():106699. PubMed ID: 34229227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring quality of life in individuals with a severe developmental and epileptic encephalopathy, CDKL5 Deficiency Disorder.
    Leonard H; Junaid M; Wong K; Demarest S; Downs J
    Epilepsy Res; 2021 Jan; 169():106521. PubMed ID: 33341033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CDKL5 Deficiency Disorder-A Complex Epileptic Encephalopathy.
    Jakimiec M; Paprocka J; Śmigiel R
    Brain Sci; 2020 Feb; 10(2):. PubMed ID: 32079229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. International Consensus Recommendations for the Assessment and Management of Individuals With CDKL5 Deficiency Disorder.
    Amin S; Monaghan M; Aledo-Serrano A; Bahi-Buisson N; Chin RF; Clarke AJ; Cross JH; Demarest S; Devinsky O; Downs J; Pestana Knight EM; Olson H; Partridge CA; Stuart G; Trivisano M; Zuberi S; Benke TA
    Front Neurol; 2022; 13():874695. PubMed ID: 35795799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CDKL5 deficiency disorder: molecular insights and mechanisms of pathogenicity to fast-track therapeutic development.
    Van Bergen NJ; Massey S; Quigley A; Rollo B; Harris AR; Kapsa RMI; Christodoulou J
    Biochem Soc Trans; 2022 Aug; 50(4):1207-1224. PubMed ID: 35997111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of the ketogenic diet to manage refractory epilepsy in CDKL5 disorder: Experience of >100 patients.
    Lim Z; Wong K; Olson HE; Bergin AM; Downs J; Leonard H
    Epilepsia; 2017 Aug; 58(8):1415-1422. PubMed ID: 28605011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aged heterozygous Cdkl5 mutant mice exhibit spontaneous epileptic spasms.
    Mulcahey PJ; Tang S; Takano H; White A; Davila Portillo DR; Kane OM; Marsh ED; Zhou Z; Coulter DA
    Exp Neurol; 2020 Oct; 332():113388. PubMed ID: 32585155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical features of early myoclonic encephalopathy caused by a CDKL5 mutation.
    Takeda K; Miyamoto Y; Yamamoto H; Ishii A; Hirose S; Yamamoto H
    Brain Dev; 2020 Jan; 42(1):73-76. PubMed ID: 31492455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A framework for understanding quality of life domains in individuals with the CDKL5 deficiency disorder.
    Tangarorang J; Leonard H; Epstein A; Downs J
    Am J Med Genet A; 2019 Feb; 179(2):249-256. PubMed ID: 30561084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Initial Validation and Reliability of the CDKL5 Deficiency Disorder Hand Function Scale (CDD-Hand).
    Saldaris J; Leonard H; Jacoby P; Marsh ED; Benke TA; Demarest S; Downs J
    J Child Neurol; 2022 May; 37(6):541-547. PubMed ID: 35422141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.